Panebianco Valeria, Pecoraro Martina, Del Giudice Francesco, Takeuchi Mitsuru, Muglia Valdair F, Messina Emanuele, Cipollari Stefano, Giannarini Gianluca, Catalano Carlo, Narumi Yoshifumi
Department of Radiological Sciences, Oncology and Pathology, Sapienza/Policlinico Umberto I, Rome, Italy.
Department of Maternal-Infant and Urological Sciences, Sapienza/Policlinico Umberto I, Rome, Italy.
J Magn Reson Imaging. 2022 Jan;55(1):23-36. doi: 10.1002/jmri.27361. Epub 2020 Sep 17.
Bladder cancer (BCa) is among the ten most frequent cancers globally. It is the tumor with the highest lifetime treatment-associated costs, and among the tumors with the heaviest impacts on postoperative quality of life. The purpose of this article is to review the current applications and future perspectives of the Vesical Imaging Reporting and Data System (VI-RADS). VI-RADS is a newly developed scoring system aimed at standardization of MRI acquisition, interpretation, and reporting for BCa. An insight will be given on the BCa natural history, current MRI applications for local BCa staging with assessment of muscle invasiveness, and clinical implications of the score for disease management. Future applications include risk stratification of nonmuscle invasive BCa, surveillance, and prediction and monitoring of therapy response. LEVEL OF EVIDENCE: 3 TECHNICAL EFFICACY STAGE: 2.
膀胱癌（BCa）是全球十大常见癌症之一。它是终生治疗相关成本最高的肿瘤，也是对术后生活质量影响最大的肿瘤之一。本文旨在综述膀胱影像报告和数据系统（VI-RADS）的当前应用及未来前景。VI-RADS是一种新开发的评分系统，旨在实现BCa的MRI采集、解读及报告的标准化。将深入探讨BCa的自然病史、当前用于局部BCa分期及评估肌肉浸润性的MRI应用，以及该评分对疾病管理的临床意义。未来应用包括非肌肉浸润性BCa的风险分层、监测以及治疗反应的预测和监测。证据水平：3 技术疗效阶段：2。
